The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia

代理(哲学) 医学 监管机构 药理学 药品 政治学 公共行政 社会学 社会科学
作者
Mototsugu Tanaka,Mutsuhiro Ikuma,Wataru Asakura,Yasuhiro Fujiwara
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:111 (2): 358-361 被引量:1
标识
DOI:10.1002/cpt.2275
摘要

Clinical Pharmacology & TherapeuticsEarly View Perspective The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia Mototsugu Tanaka, Corresponding Author motanaka-tky@umin.ac.jp Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan Correspondence: Mototsugu Tanaka (motanaka-tky@umin.ac.jp)Search for more papers by this authorMutsuhiro Ikuma, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorWataru Asakura, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorYasuhiro Fujiwara, Chief Executive, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this author Mototsugu Tanaka, Corresponding Author motanaka-tky@umin.ac.jp Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan Correspondence: Mototsugu Tanaka (motanaka-tky@umin.ac.jp)Search for more papers by this authorMutsuhiro Ikuma, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorWataru Asakura, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorYasuhiro Fujiwara, Chief Executive, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this author First published: 16 May 2021 https://doi.org/10.1002/cpt.2275Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Early ViewOnline Version of Record before inclusion in an issue RelatedInformation
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
hs完成签到,获得积分10
1秒前
烟花应助jgtrd采纳,获得10
1秒前
繁荣的白亦完成签到 ,获得积分10
1秒前
李狗蛋完成签到 ,获得积分10
1秒前
XLL小绿绿发布了新的文献求助10
2秒前
2秒前
汉堡包应助aa采纳,获得10
3秒前
3秒前
慕青应助难过的谷芹采纳,获得10
4秒前
6秒前
和谐的寄凡完成签到,获得积分10
6秒前
7秒前
8秒前
品品发布了新的文献求助10
8秒前
8秒前
无极微光应助zbm采纳,获得20
8秒前
zhujingyao完成签到,获得积分10
9秒前
12秒前
小小发布了新的文献求助10
13秒前
betterme发布了新的文献求助30
13秒前
13秒前
13秒前
sayso发布了新的文献求助10
14秒前
ding应助白河采纳,获得30
14秒前
14秒前
14秒前
superfatcat完成签到,获得积分10
15秒前
量子星尘发布了新的文献求助10
16秒前
16秒前
hhh完成签到,获得积分10
16秒前
16秒前
kks569发布了新的文献求助10
17秒前
17秒前
好好完成签到 ,获得积分10
17秒前
吴玉杰完成签到,获得积分10
17秒前
品品完成签到,获得积分10
17秒前
Akim应助熙原采纳,获得10
18秒前
19秒前
ZHN完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.).. Frederic G. Reamer 1070
Alloy Phase Diagrams 1000
Introduction to Early Childhood Education 1000
2025-2031年中国兽用抗生素行业发展深度调研与未来趋势报告 1000
List of 1,091 Public Pension Profiles by Region 891
Historical Dictionary of British Intelligence (2014 / 2nd EDITION!) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5424333
求助须知:如何正确求助?哪些是违规求助? 4538732
关于积分的说明 14163572
捐赠科研通 4455641
什么是DOI,文献DOI怎么找? 2443832
邀请新用户注册赠送积分活动 1434995
关于科研通互助平台的介绍 1412304